Investing.comCodex · 实盘不做把握 5/10
北京时间·🕒 发布 08:08:36时区推断·⟳ 抓取 12:45:12·⚡ 决策 08-05 14:39:29 +1h54m·83.0 天前
ARK减持Palantir约492.96万美元并买入GeneDx约497.88万美元
ARK卖出Palantir 39233股、约492.96万美元，同时买入GeneDx 73368股、约497.88万美元。
📄 原文Investing.com↗ 原文
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings
SpaceX shares fall on AI spending concerns; Musk says $1 trln revenue possible Cathie Wood’s ARK ETF published their da…
不做 Palantir Technologies（PLTR.US）
基金调仓不是公司级经营催化，卖出金额相对市值太小，不做。
不做 GeneDx Holdings（WGS.US）
ARK买入只能说明基金配置变化，缺少公司基本面新增事实，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-04 · 扩散 medium · price-in 风险 high ↗
关键理由
- ARK卖出Palantir 39233股、约492.96万美元，同时买入GeneDx 73368股、约497.88万美元。
- 单一基金日度调仓是持仓再平衡，不直接改变Palantir或GeneDx的收入、利润或经营预期。
主要风险
- 容易被误读为基本面判断，但正文没有披露公司新订单、业绩或监管催化。
工具调用 · 历史记录,结果未知(3 种)
- search_processed_events · 结果未知
- kb_search · 结果未知
- stock_quote · 结果未知
原文全文
展开原文 · 1,866 字
SpaceX shares fall on AI spending concerns; Musk says $1 trln revenue possible
Cathie Wood’s ARK ETF published their daily trades for Tuesday, August 4th, 2026, showcasing a mix of strategic buys and significant reductions in several holdings. The most notable transaction of the day was the sale of 39,233 shares of Palantir Technologies Inc. (NYSE:PLTR), totaling $4,929,626. This marks a continuation of ARK’s recent trend of reducing its position in Palantir, following sales in prior days.
On the buying side, ARK made a substantial purchase of 73,368 shares of GeneDx Holdings Corp. (NASDAQ:WGS), amounting to $4,978,752. This purchase is a significant addition to ARK’s portfolio, indicating a potential strategic interest in the company.
In other trades, ARK sold 275,338 shares of ATAI Life Sciences N.V. (NASDAQ:ATAI) for $1,976,926 and 24,454 shares of 10X Genomics, Inc. (NASDAQ:TXG) for $1,149,582, continuing its sell-off of these stocks from previous days. The firm also offloaded 3,189 shares of Natera, Inc. (NASDAQ:NTRA) valued at $862,178.
Conversely, ARK increased its stake in Spotify Technology S.A. (NYSE:SPOT), buying 5,128 shares for $2,493,900, suggesting confidence in the company’s future prospects.
Smaller trades included the sale of 27,621 shares of Komatsu Ltd. (TYO:6301) for $1,210,092, and a minor addition of 5,500 shares of Pony AI Inc. (PONY) for $44,275.
Overall, ARK’s trades reflect a strategic rebalancing of its portfolio, with a clear focus on increasing positions in select companies like GeneDx Holdings and Spotify, while continuing to trim its holdings in others such as Palantir and ATAI Life Sciences. Investors will be watching closely to see how these moves align with ARK’s broader investment strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Cathie Wood’s ARK ETF published their daily trades for Tuesday, August 4th, 2026, showcasing a mix of strategic buys and significant reductions in several holdings. The most notable transaction of the day was the sale of 39,233 shares of Palantir Technologies Inc. (NYSE:PLTR), totaling $4,929,626. This marks a continuation of ARK’s recent trend of reducing its position in Palantir, following sales in prior days.
On the buying side, ARK made a substantial purchase of 73,368 shares of GeneDx Holdings Corp. (NASDAQ:WGS), amounting to $4,978,752. This purchase is a significant addition to ARK’s portfolio, indicating a potential strategic interest in the company.
In other trades, ARK sold 275,338 shares of ATAI Life Sciences N.V. (NASDAQ:ATAI) for $1,976,926 and 24,454 shares of 10X Genomics, Inc. (NASDAQ:TXG) for $1,149,582, continuing its sell-off of these stocks from previous days. The firm also offloaded 3,189 shares of Natera, Inc. (NASDAQ:NTRA) valued at $862,178.
Conversely, ARK increased its stake in Spotify Technology S.A. (NYSE:SPOT), buying 5,128 shares for $2,493,900, suggesting confidence in the company’s future prospects.
Smaller trades included the sale of 27,621 shares of Komatsu Ltd. (TYO:6301) for $1,210,092, and a minor addition of 5,500 shares of Pony AI Inc. (PONY) for $44,275.
Overall, ARK’s trades reflect a strategic rebalancing of its portfolio, with a clear focus on increasing positions in select companies like GeneDx Holdings and Spotify, while continuing to trim its holdings in others such as Palantir and ATAI Life Sciences. Investors will be watching closely to see how these moves align with ARK’s broader investment strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。